Form 4 holding
Former President & CEO
Adamis Pharmaceuticals Corp
- Security class
- Common Stock
- Shares / value
- 535,867
- Estimated value
- $323,449
- Report date
- 25 May 2022
- Price
- $0.6036
- Ownership
- Direct
Dennis J. Carlo PhD - Former President & CEO at DMK PHARMACEUTICALS Corp
Issuer-level insider activity
- Role
- Former President & CEO
- Issuer ticker
- ADMP
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Dennis J. Carlo PhD since 13 Sep 2025
Reported holdings for Dennis J. Carlo PhD in DMK PHARMACEUTICALS Corp
Form 4 holding
Former President & CEO
Adamis Pharmaceuticals Corp
- Security class
- Common Stock
- Shares / value
- 150,709
- Estimated value
- $90,968
- Report date
- 25 May 2022
- Price
- $0.6036
- Ownership
- By Dennis and Allison Carlo Joint Living Trust
Form 4 holding
Former President & CEO
Adamis Pharmaceuticals Corp
- Security class
- Common Stock
- Shares / value
- 5,883
- Estimated value
- $3,551
- Report date
- 25 May 2022
- Price
- $0.6036
- Ownership
- By A.Carlo as custodian for Child
Form 4 holding
Former President & CEO
Adamis Pharmaceuticals Corp
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 25 May 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Dennis J. Carlo PhD in DMK PHARMACEUTICALS Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.